Jack Henry (JKHY) ·

Jack Henry Director Gifts Shares Following Upbeat Q1 Earnings

Director Matthew C. Flanigan gifted 1,175 shares of Jack Henry & Associates at zero cost. The transaction follows strong fiscal first-quarter financial results and target price increases from analysts.

Traders on the floor of the New York Stock Exchange

Director Matthew C. Flanigan of Jack Henry & Associates disclosed transferring 1,175 shares of common stock as a gift on November 9, 2026. According to a Form 4 filed with the Securities and Exchange Commission on November 10, 2026, the transaction occurred at a price of $0. Following the gift, Flanigan retains direct beneficial ownership of 43,279 shares.

The insider transaction follows the company's fiscal 2027 first-quarter report. Jack Henry filed its Form 10-Q for the quarter ended September 30, 2026, showing revenue reached $701,547 thousand, up from $644,738 thousand in the prior-year period. Net income climbed to $160,412 thousand from $143,986 thousand, while diluted earnings per share expanded to $2.28 compared to $1.97 a year earlier. Separate reports noted quarterly revenue at $682.18 million versus an estimated $685.54 million, while Yahoo Finance reported that both revenue and earnings came in ahead of expectations.

Driven by expansion in cloud and payments, the company elevated its fiscal 2027 GAAP earnings outlook to between $7.47 and $7.51 per share, while aiming for 58 to 65 new core wins. As of September 30, 2026, the firm held total assets of $3,194,748 thousand, stockholders' equity of $2,099,643 thousand, and long-term debt of $85,000 thousand.

Wall Street analysts adjusted their outlooks following the quarterly earnings release. Equities research analysts at UBS Group increased their target price on the stock from $170.00 to $185.00 while maintaining a neutral rating. Barclays raised its objective from $185.00 to $190.00 with an overweight rating. Keefe, Bruyette & Woods lifted its target from $200.00 to $215.00 with an outperform rating, and RBC adjusted its objective to $195.00. Across brokerage reports compiled by MarketBeat, the company carried a consensus Moderate Buy rating.